Roddy E, Doherty M, Roddy E, Zhang W, Doherty M, Singh J, et al. Gout. Epidemiology of gout. Arthritis Res Ther. 2010;12:223. https://doi.org/10.1186/ar3199.
Article
PubMed
PubMed Central
Google Scholar
Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol. 2006;18:199–203. https://doi.org/10.1097/01.bor.0000209435.89720.7c.
Article
PubMed
Google Scholar
Singh JA, Yu S. Time trends, predictors, and outcome of emergency department use for gout: a nationwide US study. J Rheumatol. 2016;43. https://doi.org/10.3899/jrheum.151419.
Rai SK, Burns LC, De Vera MA, Haji A, Giustini D, Choi HK. The economic burden of gout: a systematic review. Semin Arthritis Rheum. 2015;45:75–80. https://doi.org/10.1016/j.semarthrit.2015.02.004.
Article
PubMed
Google Scholar
Singh JA. The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout. Arthritis Res Ther. 2014;16:R132. https://doi.org/10.1186/ar4589.
Article
PubMed
PubMed Central
Google Scholar
Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout 2007. doi:https://doi.org/10.1093/rheumatology/kem056b.
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American college of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431–46. https://doi.org/10.1002/acr.21772.
Article
CAS
Google Scholar
Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American college of rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 2012;64:1447–61. https://doi.org/10.1002/acr.21773.
Article
CAS
Google Scholar
Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology. 2009;48. https://doi.org/10.1093/rheumatology/kep087.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–24. https://doi.org/10.1136/ard.2006.055269.
Article
CAS
PubMed
PubMed Central
Google Scholar
Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67:960–6. https://doi.org/10.1136/ard.2007.076232.
Article
CAS
PubMed
Google Scholar
Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661–7. https://doi.org/10.1136/annrheumdis-2013-204463.
Article
PubMed
Google Scholar
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK general practice research database (GPRD). Rheumatology. 2005;44:1038–42. https://doi.org/10.1093/rheumatology/keh679.
Article
CAS
PubMed
Google Scholar
Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol. 2006;33:104–9.
PubMed
Google Scholar
Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66:1311–5. https://doi.org/10.1136/ard.2007.070755.
Article
CAS
PubMed
PubMed Central
Google Scholar
Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout Classification Criteria An American College of Rheumatology / European League Against Rheumatism Collaborative Initiative 2015;67:2557–2568. doi:https://doi.org/10.1002/art.39254.
Juraschek SP, Kovell LC, Miller ER III, Gelber AC. Gout, urate lowering therapy and uric acid levels among US adults. Arthritis Care Res. 2015;67:588–92. https://doi.org/10.1002/acr.22469.
Article
CAS
Google Scholar
Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120:442–7. https://doi.org/10.1016/j.amjmed.2006.06.040.
Article
PubMed
Google Scholar
Robinson PC, Taylor WJ, Dalbeth N. An observational study of gout prevalence and quality of care in a national australian general practice population. J Rheumatol. 2015;42:1702–7. https://doi.org/10.3899/jrheum.150310.
Article
CAS
PubMed
Google Scholar
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007-2008. Arthritis Rheum. 2011;63:3136–41. https://doi.org/10.1002/art.30520.
Article
PubMed
Google Scholar
Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17:90. https://doi.org/10.1186/s13075-015-0610-9.
Article
PubMed
PubMed Central
Google Scholar
Fuldeore MJ, Riedel AA, Zarotsky V, Pandya BJ, Dabbous O, Krishnan E. Chronic kidney disease in gout in a managed care setting. BMC Nephrol. 2011;12:36. https://doi.org/10.1186/1471-2369-12-36.
Article
PubMed
PubMed Central
Google Scholar
Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, et al. Quality of care indicators for gout management. Arthritis Rheum. 2004;50:937–43. https://doi.org/10.1002/art.20102.
Article
PubMed
Google Scholar
El-Zawawy H, Mandell BF. Managing gout: how is it different in patients with chronic kidney disease? Cleve Clin J Med. 2010;77:919–28. https://doi.org/10.3949/ccjm.77a.09080.
Article
PubMed
Google Scholar
Coburn BW, Mikuls TR. The problem with gout is that it’s still such a problem. J Rheumatol. 2016;43:1453–5. https://doi.org/10.3899/jrheum.160614.
Article
PubMed
Google Scholar
Prasad Sah OS, Qing YX. Associations between hyperuricemia and chronic Kidney Disease: a review. Nephrourol Mon. 2015;7:online My23 2015. https://doi.org/10.5812/numonthly.7(3)2015.27233.
Lee Y-Y, Tang C-H, Chen J-H, Kuo L-N, Ko Y. Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study. Curr Med Res Opin. 2018;34:735–40. https://doi.org/10.1080/03007995.2017.1417826.
Article
PubMed
Google Scholar
Jinno S, Hasegawa K, Neogi T, Goto T, Dubreuil M. Trends in emergency department visits and charges for gout in the United States between 2006 and 2012. J Rheumatol. 2016;43:1589–92. https://doi.org/10.3899/jrheum.151432.
Article
PubMed
PubMed Central
Google Scholar
Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, et al. Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res (Hoboken). 2013;65:571–7. https://doi.org/10.1002/acr.21837.
Article
Google Scholar
Morlock R, Flores NM, Annunziata K, Chapnick J, Nuevo J. Economic burden of controlled gout, uncontrolled gout, and gout exacerbated by common comorbidities: results from the 2012-2013 national health and wellness survey. Ann Rheum Dis. 2015;74:550. https://doi.org/10.1136/annrheumdis-2015-eular.5055.
Article
Google Scholar
Wertheimer A, Morlock R, Becker MA. A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp. 2013;75:1–4. https://doi.org/10.1016/j.curtheres.2013.04.003.
Article
PubMed
PubMed Central
Google Scholar
Cohen R, Rabin H. Membership in health plans 2013. Jerusalem: Report of the National Health Insurance Institute [Hebrew]; 2014.
Krishnan E, Akhras K, Sharma H, Marynchenko M, Wu E, Tawk R, et al. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. Qjm. 2013;106:721–9. https://doi.org/10.1093/qjmed/hct093.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW. Serum urate levels and gout flares. JCR J Clin Rheumatol. 2006;12:61–5. https://doi.org/10.1097/01.rhu.0000209882.50228.9f.
Article
PubMed
Google Scholar
Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel 2013:1–6. doi:https://doi.org/10.1093/rheumatology/kes431.
Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001;3:404–8.
CAS
PubMed
Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Article
Google Scholar
Galobardes B, Lynch J, Smith GD. Measuring socioeconomic position in health research. Br Med Bull. 2007;81–82:21–37. https://doi.org/10.1093/bmb/ldm001.
Article
PubMed
Google Scholar
Darin-Mattsson A, Fors S, Kåreholt I. Different indicators of socioeconomic status and their relative importance as determinants of health in old age. Int J Equity Health. 2017;16:173. https://doi.org/10.1186/s12939-017-0670-3.
Article
PubMed
PubMed Central
Google Scholar
Israel Central Bureau of Statistics. Characterization and classification of geographical units by the socio-economic level of the population. In: Census of population and housing [Hebrew]. Jerusalem: Israel Central Bureau of Statistics; 1995. p. 1999.
Israel Central Bureau of Statistics. Characterization and classification of geographical units by the socio-economic level of the population, 2008 census of population and housing [Hebrew]. Jerusalem: Israel Central Bureau of Statistics; 2013.
Karpati T, Cohen-Stavi CJ, Leibowitz M, Hoshen M, Feldman BS, Balicer RD. Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel. Popul Health Metrics. 2014;12:32. https://doi.org/10.1186/s12963-014-0032-y.
Article
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Article
CAS
Google Scholar
Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodriguez LAG. Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology. 2011;50:973–81. https://doi.org/10.1093/rheumatology/keq363.
Article
PubMed
Google Scholar
Israel Central Bureau of Statistics. Statistical abstract of Israel 2010 (Vol. no. 61). Jerusalem: Israel Central Bureau of Statistics; 2010.
Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease : the German Chronic Kidney Disease ( GCKD ) study 2014:2253–2259. doi:https://doi.org/10.1093/ndt/gfu352.
Teng G, Ang L, Saag K, Yu M, Yuan J, Koh W. Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese health study. Ann Rheum Dis. 2012;71:924–8.
Article
Google Scholar
Jalal DI. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Curr Med Res Opin. 2016;32:1863–9.
Article
CAS
Google Scholar
Ryu H, Song R, Kim H, Kim J, Lee E, Lee Y, et al. Clinical risk factors for adverse events in allopurinol users. J Clin Pharmacol. 2013;53:211–6.
Article
CAS
Google Scholar
Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis. 2015;65:543–9.
Article
CAS
Google Scholar
Kanji T, Gandhi M, Clase CM, Yang R. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2015;16:58. https://doi.org/10.1186/s12882-015-0047-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
KIDGO. Kidney Disease: Improving global outcomes (KDIGO) CKD work group. Kidney Int Suppl. 2013;3(4). https://doi.org/10.1038/kisup.2012.76.
Kuo C-F, Grainge MJ, See L-C, Yu K-H, Luo S-F, Zhang W, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2015;17:13. https://doi.org/10.1186/s13075-015-0522-8.
Article
PubMed
PubMed Central
Google Scholar
Dehlin M, Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther. 2016;18:164. https://doi.org/10.1186/s13075-016-1062-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hayward RA, Rathod T, Roddy E, Muller S, Hider SL, Mallen CD. The association of gout with socioeconomic status in primary care: a cross-sectional observational study. Rheumatology. 2013;52:2004–8. https://doi.org/10.1093/rheumatology/ket262.
Article
PubMed
Google Scholar